Insiders Buy Into Boston Scientific Restructuring
Three Boston Scientific executives added $9.3 million in shares as the company accelerates cost reduction initiatives.
Coverage: 8 of 14 companies in this theme (GBFH, CAMP, ORN, FUNC, BSX, TSCO, MKZR, MBRX) — a sample, not the full set.
Boston Scientific Corp is accelerating restructuring and cost reduction initiatives across its operations. Three insiders, including directors and an officer, bought 192,422 shares during the window ending August 6, totaling $9.3 million in priced value.
This conviction appears within a broader pattern of cluster buying across the financial and industrial sectors. GBank Financial Holdings Inc. saw four distinct buyers, including three officers and three directors, purchase 56,463 shares for $1.2 million.
Orion Group Holdings Inc. also drew four distinct buyers. Two officers and two directors acquired 33,025 shares for $320,840.
Other activity concentrated in smaller-cap issuers. Tractor Supply Co. saw three insiders buy 20,310 shares for $652,394, while MacKenzie Realty Capital saw three insiders acquire 199,800 shares for $262,818.
Camp4 Therapeutics and First United Corp also recorded four distinct buyers each [2, 4]. Camp4 insiders bought 36,031 shares for $59,451, and First United insiders acquired 280 shares for $12,801.
Moleculin Biotech saw three insiders purchase 999,999 shares, though these transactions remained unpriced.